/PRNewswire/ The Global Genetic Toxicology Testing Market size is expected to reach $2.4 billion by 2028, rising at a market growth of 13.2% CAGR during the.
Pursuant to its July-Aug 2022 audit of Jubilant Generics Ltd s Solid Dosage Manufacturing facility at Roorkee it has determined inspection classification of the facility as official action indicated .
The Board of Directors of Jubilant Pharmova Limited have approved the financial results of the company for the period ended September 30, 2022 - Q2FY23, H1FY23 at its board meeting.
Market watchers believe that the recent turmoil in the global economy due the Russia-Ukraine conflict, soaring crude prices, currency depreciation and ballooning inflation all around the globe have hammered the stock market returns in most of the countries.